Elasmogen Ltd

Activities: Pharmaceutical

Trending Articles

  1. Enhancing solubility with novel excipients With the growing prevalence of complex drug molecules, formulation is becoming ever more challenging. Novel excipients can unlock their potential, says Meera Raghuram, Director...
  2. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  3. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  4. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  5. SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Analysis

Almac Discovery and Elasmogen to share Anti-ROR-1 VNAR data

Research & Development

Almac Discovery, Elasmogen and Innovate UK collaborate

The £2 million collaborative project will aim to build a versatile platform to facilitate the discovery and development of targeted oncology therapeutics
Subscribe now